Concepedia

Publication | Open Access

Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma

DOIFull Paper Access

95

Citations

33

References

2012

Year

Motoo Nagane, Ryo Nishikawa, Yusuke Narita, H. Kobayashi, Shingo Takano, Nobusada Shinoura, Taku Aoki, Keiji Sugiyama, J. Kuratsu, Yoshihiro Muragaki,
Japanese Journal of Clinical Oncology

Abstract

Single-agent bevacizumab provides clinical benefit for Japanese patients with recurrent glioblastoma.

References

YearCitations

Page 1